metabolic
Orforglipron
Oral small-molecule GLP-1 agonist
0 vendors tracked0 live pricesLast crawl: 2026-06-10 06:03 UTC
About
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
Also known as: LY-3502970
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on Orforglipron & related research
Related peptides
- Semaglutide— GLP-1 agonist for metabolic research
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Mazdutide— GLP-1/glucagon dual agonist
- Survodutide— Glucagon/GLP-1 dual agonist
Compare head-to-head